Patients today are more involved in their healthcare choices than ever before, and gaining access to accurate, relevant and easily understandable information can help empower them to make more ...

In a time when COAs are more nuanced, critical and complex than ever, researchers can turn to best practices to move forward ...

Together, the panelists discussed the multifaceted challenges that rural communities face in accessing clinical trials and offered actionable strategies to overcome these barriers. Breaking Down ...

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient access. The high closure rate of trial sites reflects unique research objectives ...

Clinical trials stand as a cornerstone in the continuous quest for advancing medical knowledge and patient care. These research studies test new ways to prevent, detect or treat diseases and are ...

Among the many catchphrases of the Affordable Care Act individual mandates, pre-existing conditions clinical trials is one that has flown under the radar. But in terms of immediate impact, it is one ...

Digital databases for clinical trial searches have already changed healthcare accessibility, bringing critical information about clinical trials to the patients who need it – and to the physicians who ...

Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.

Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...

A cancer diagnosis presents patients with complex treatment decisions. While traditional therapies like surgery, chemotherapy, and radiation remain standard options, clinical trials offer additional ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...